{
  "selftext": "News was put out by the company earlier this month that was not caught on the main wires.\n\n Looks like they are trying to turn the company around and bringing in the big wigs to do it!\n\nWatch out for this one! It moved with heavy volume today and got people excited. \n\nIm buying more .0004s tomorrow as i expect to see a 500% return at least from there levels!\n\n\nRecent news earlier this month:\n\n\n\nUNIVEC Announces Appointment for Chairman of Financial Advisory Board \n\n\nOwings Mills, MD, July 03, 2014 --(PR.com)-- Univec, Inc. (UNVC) a specialty pharmaceutical company, announces the appointment for Chairman of the Financial Advisory Board (\"CFAB\" or \"Chairman\") Robert M. Cohen of Revolution Investment Management based in New York. Mr. Cohen will be responsible for overseeing operations in finance. With over 32 years in the investment industry Mr. Cohen was Founder and President of Robert M. Cohen and Co., a full service brokerage firm specializing in investment banking , research and marketing making. \n\nDavid L. Dalton, President and CEO of Univec stated, \u201cWe are delighted to have reached this agreement with such a seasoned professional. Mr. Cohen's expertise will lead the company's financial operations and funding process for expanding and moving forward.\u201d \n\nAbout Univec \nUnivec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that manufactures and distributes transdermal patches and high cost Specialty Pharmaceuticals. Recent NDC approvals by the FDA provides a niche market for smoking cessation, nicotine replacement products and pain management along with behavioral health pharmaceuticals. \n\nForward Looking Statements \nThis document may contain forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in Univec\u2019s business. These risks and uncertainties include, but are not limited to, the risks described from time to time in Univec\u2019s reports to the General Public and reporting agencies. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in Univec\u2019s reports filed \n\nUnivec Inc. \nThe Specialty Pharmaceutical Company \n\nContact: \nDavid Dalton, President \n\n\n\n\nContact Information \nUnivec Inc. \nDavid Dalton \n443-253-0194 \n\nhttp://www.pr.com/press-release/567501",
  "gilded": 0,
  "score": 5,
  "removal_reason": null,
  "approved_by": null,
  "created_utc": 1406694434.0,
  "is_self": true,
  "stickied": false,
  "edited": false,
  "distinguished": null,
  "permalink": "https://www.reddit.com/r/pennystocks/comments/2c42jh/unvc_0004_soars_300_in_a_day/?ref=search_posts",
  "banned_by": null,
  "from_id": null,
  "likes": null,
  "_underscore_names": null,
  "num_reports": null,
  "link_flair_css_class": null,
  "_info_url": "https://api.reddit.com/api/info/",
  "id": "2c42jh",
  "archived": true,
  "secure_media": null,
  "from_kind": null,
  "saved": false,
  "domain": "self.pennystocks",
  "ups": 5,
  "suggested_sort": null,
  "quarantine": false,
  "over_18": false,
  "hide_score": false,
  "url": "https://www.reddit.com/r/pennystocks/comments/2c42jh/unvc_0004_soars_300_in_a_day/",
  "subreddit_id": "t5_2qqoq",
  "_params": {},
  "_comments": null,
  "_replaced_more": false,
  "_comments_by_id": {},
  "user_reports": [],
  "media_embed": {},
  "created": 1406698034.0,
  "author_flair_text": null,
  "visited": false,
  "selftext_html": "<!-- SC_OFF --><div class=\"md\"><p>News was put out by the company earlier this month that was not caught on the main wires.</p>\n\n<p>Looks like they are trying to turn the company around and bringing in the big wigs to do it!</p>\n\n<p>Watch out for this one! It moved with heavy volume today and got people excited. </p>\n\n<p>Im buying more .0004s tomorrow as i expect to see a 500% return at least from there levels!</p>\n\n<p>Recent news earlier this month:</p>\n\n<p>UNIVEC Announces Appointment for Chairman of Financial Advisory Board </p>\n\n<p>Owings Mills, MD, July 03, 2014 --(PR.com)-- Univec, Inc. (UNVC) a specialty pharmaceutical company, announces the appointment for Chairman of the Financial Advisory Board (&quot;CFAB&quot; or &quot;Chairman&quot;) Robert M. Cohen of Revolution Investment Management based in New York. Mr. Cohen will be responsible for overseeing operations in finance. With over 32 years in the investment industry Mr. Cohen was Founder and President of Robert M. Cohen and Co., a full service brokerage firm specializing in investment banking , research and marketing making. </p>\n\n<p>David L. Dalton, President and CEO of Univec stated, \u201cWe are delighted to have reached this agreement with such a seasoned professional. Mr. Cohen&#39;s expertise will lead the company&#39;s financial operations and funding process for expanding and moving forward.\u201d </p>\n\n<p>About Univec \nUnivec, Inc. A minority business enterprise (MBE) is a Specialty Pharmaceutical Company that manufactures and distributes transdermal patches and high cost Specialty Pharmaceuticals. Recent NDC approvals by the FDA provides a niche market for smoking cessation, nicotine replacement products and pain management along with behavioral health pharmaceuticals. </p>\n\n<p>Forward Looking Statements \nThis document may contain forward-looking statements based on current expectations that could be affected by the risks and uncertainties involved in Univec\u2019s business. These risks and uncertainties include, but are not limited to, the risks described from time to time in Univec\u2019s reports to the General Public and reporting agencies. Subsequent written or oral statements attributable to Univec or persons acting on its behalf are expressly qualified in their entirety by the cautionary statements in this document and those in Univec\u2019s reports filed </p>\n\n<p>Univec Inc. \nThe Specialty Pharmaceutical Company </p>\n\n<p>Contact: \nDavid Dalton, President </p>\n\n<p>Contact Information \nUnivec Inc. \nDavid Dalton \n443-253-0194 </p>\n\n<p><a href=\"http://www.pr.com/press-release/567501\">http://www.pr.com/press-release/567501</a></p>\n</div><!-- SC_ON -->",
  "downs": 0,
  "_comment_sort": null,
  "report_reasons": null,
  "name": "t3_2c42jh",
  "from": null,
  "hidden": false,
  "clicked": false,
  "media": null,
  "json_dict": null,
  "_api_link": "https://api.reddit.com/r/pennystocks/comments/2c42jh/unvc_0004_soars_300_in_a_day/?ref=search_posts",
  "secure_media_embed": {},
  "mod_reports": [],
  "_orphaned": {},
  "_uniq": null,
  "num_comments": 0,
  "link_flair_text": null,
  "title": "UNVC - .0004 soars 300% in a day!",
  "_has_fetched": true,
  "author_flair_css_class": null,
  "thumbnail": ""
}